1.
Agarwal R, Goel A, Rai J, Kajal NC. Pharmacovigilance of first line anti-tubercular therapy in category I patients of pulmonary tuberculosis. Int J Basic Clin Pharmacol [Internet]. 2017 Feb. 24 [cited 2025 Sep. 29];6(3):643-7. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/1487